Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
University of Chicago
University of Chicago
AstraZeneca
DEKA Biosciences
Taiho Pharmaceutical Co., Ltd.
Merck Sharp & Dohme LLC
Orient Europharma Co., Ltd.
Gustave Roussy, Cancer Campus, Grand Paris
Genentech, Inc.
Valerio Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Galectin Therapeutics Inc.